AzTrials
AzTrials

Fistula of Soft Palate (Disorder)NCT03055637

Evaluation of the Incidence of Palatal Fistula in Furlow Double-opposing Z-plasty vs. Two-flap Palatoplasty for Cleft Palate Repair

A study testing Furlow double opposing z-plasty and Two flap palatoplasty in people with Fistula of Soft Palate (Disorder), run by Sarah Moustafa Mahmoud Fahmy El-Youtti.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation of the incidence of palatal fistula in Furlow double-opposing z-plasty versus two-flap palatoplasty for cleft palate repair. Read more about this study

Who is it for?
Ages 9 to 12 monthsHealthy volunteers can take part
Conditions the study is for
Fistula of Soft Palate (Disorder)
What is being tested?
Furlow double opposing z-plasty and Two flap palatoplasty
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
19 Feb 2017to 19 May 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 12 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age of Repair from 9 to 12 months.
  • Isolated Cleft Palate
  • Operation time should nearly be the same for all patients
  • Surgical skills done by same surgeon
  • Both sexes

Who cannot join

  • Patients with hypoplasia of palatal tissue.
  • Patients with associated anomalies.
  • Patients with associated syndromes.
  • Other types of cleft palate.

About this study

Evaluation of the incidence of palatal fistula in Furlow double-opposing z-plasty versus two-flap palatoplasty for cleft palate repair.

Read the detailed description

Up to 6 hours before the scheduled arrival time, formula-fed babies may be given formula. Up to 4 hours before the scheduled arrival time, breastfed babies may nurse. Up to 2 hours before the scheduled arrival time, give only clear liquids. Clear liquids include water, Pedialyte®, Kool-Aid® and juices you can see through, such as apple or white grape juice. In the 2 hours before the scheduled arrival time, give nothing to eat or drink. Induction of general anaesthesia will be administered followed by local anaethesia. Then, Surgical prodecure will be done either following the conventional two flap palatoplasty technique or the Furlow double-opposing z-plasty technique.

Being tested
Furlow double opposing z-plasty, Two flap palatoplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Furlow double opposing z-plastyProcedure or surgery

    • Furlow, (1986) has described a technique for palatoplasty combining the principles of mucosal lengthening with creation of an intact muscular sling in the palate with double opposing Z-plasty. On the soft palate, mirror image Z-plasties are drawn, one for the nasal musoca and the other oral flaps, the nasal flaps are developed and closed first .The oral flaps are then approximated. The defect created usually closes readily. The closure lines of the two soft plate layers do not overlap, minimizing the potential for contracture. Also, this repair permits closure of the hard palate without lateral incisions
  • Two flap palatoplastyProcedure or surgery

    design the 2-flap palatoplasty, with a 2-layer closure in the hard palate and 3-layer closure in the soft palate,

Study groups in NCT03055637
Study groupRoleWhat they receive
patients with isolated cleft palateActive comparatorPatients requiring isolated cleft palate repair
Receives: Procedure: Furlow double opposing z-plasty; Procedure: Two flap palatoplasty
Patients with isolated cleft palateActive comparatorPatients requiring isolated cleft palate repair
Receives: Procedure: Furlow double opposing z-plasty; Procedure: Two flap palatoplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of fistula

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2017
  2. Study start19 Feb 2017 (estimated)
  3. Primary completion19 May 2017 (estimated)
  4. Study completion19 May 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03055637
Sponsor's protocol ID
28902051202049
Status last verified
Feb 2017
First submitted
14 Feb 2017
Last updated
16 Feb 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Furlow double opposing z-plasty and Two flap palatoplasty in people with Fistula of Soft Palate (Disorder), run by Sarah Moustafa Mahmoud Fahmy El-Youtti.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of fistula (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2017; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in